Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices 94763 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on August 22, 2024, Curia 

Wisconsin, Inc., 870 Badger Circle, 

Grafton, Wisconsin 53024–9436, 

applied to be registered as an importer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric Acid.2010 I 

Marihuana Extract .... 7350 I 

Marihuana ................. 7360 I 

Dimethyltryptamine ... 7435 I 

The company plans to import the 

listed controlled substances for 

analytical testing or distribution. No 

other activities for these drug codes are 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2024–28063 Filed 11–27–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1460] 

Importer of Controlled Substances 

Application: Cambrex Charles City 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Cambrex Charles City has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplementary 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants, therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before December 30, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before December 30, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on June 18, 2024, Cambrex 

Charles City, 1205 11th Street, Charles 

City, Iowa 50616–3466, applied to be 

registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Psilocybin ........................ 7437 I 

4-Anilino-N-phenethyl-4- 

piperidine (ANPP).

8333 II 

Phenylacetone ................. 8501 II 

Coca Leaves ................... 9040 II 

Opium Raw ...................... 9600 II 

Poppy Straw Concentrate 9670 II 

The company plans to import 

psilocybin for formulation development 

and clinical trial support for their 

customers. The remaining listed 

controlled substances will be imported 

to support the manufacture into other 

controlled substances which will be 

distributed to their customers. No other 

activities for these drug codes are 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2024–28064 Filed 11–27–24; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0059] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Extension of a 

Previously Approved Collection; 

Registration for Controlled Substances 

Act Data-Use Request 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Department of Justice 

(DOJ), Drug Enforcement 

Administration (DEA), will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 30 days until 

December 30, 2024. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact Heather E. Achbach, Regulatory 

Drafting and Policy Support Section, 

Drug Enforcement Administration; 

Mailing Address: 8701 Morrissette 

Drive, Springfield, Virginia 22152; 

Telephone: (571) 776–3882; Email: 

DEA.PRA@dea.gov or 

Heather.E.Achbach@dea.gov. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on September 24, 2024, at 89 

FR 77895, allowing for a 60-day 

comment period. Written comments and 

suggestions from the public and affected 

agencies concerning the proposed 

collection of information are 

encouraged. Your comments should 


khammond on DSK9W7S144PROD with NOTICES
94764 Federal Register / Vol. 89, No. 230 / Friday, November 29, 2024 / Notices 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and/or 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Written comments and 

recommendations for this information 

collection should be submitted within 

30 days of the publication of this notice 

on the following website 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function and entering either the title of 

the information collection or the OMB 

Control Number 1117–0059. This 

information collection request may be 

viewed at www.reginfo.gov. Follow the 

instructions to view Department of 

Justice, information collections 

currently under review by OMB. 

DOJ seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOJ notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 

Overview of This Information 

Collection: 

1. Type of Information Collection: 

Extension of a previously approved 

collection. 

2. Title of the Form/Collection: 

Registration for CSA Data-Use Request. 

3. Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: No form number is 

associated with this collection. The 

applicable component within the 

Department of Justice is the Drug 

Enforcement Administration, Diversion 

Control Division. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: 

Affected public (Primary): Business or 

other for-profit. 

Affected public (Other): Not-for-profit 

institutions; Federal, State, Local, and 

tribal governments. 

5. Abstract: In accordance with the 

Controlled Substance Act (CSA), every 

person who manufactures, distributes, 

dispenses, conducts research with, 

imports, or exports any controlled 

substance to obtain a registration issued 

by the Attorney General. 21 U.S.C. 822, 

823, and 957. While DEA registrants are 

able to self-verify their registration 

status, non-registrants do not have an 

obligation to register under the CSA, 

and therefore does not have an 

automatic means to verify the 

registration of a DEA-registrant. Nonregistrants have obligations to verify the 

registration statuses before doing things 

such as hiring practitioners, paying for 

controlled substance prescriptions 

covered by Medicaid or Medicare, and 

other means that are apart of commerce. 

This proposed collection would allow 

non-registrants to register for access to 

the CSA Database System, which gives 

the names and registration statuses of all 

DEA-registrants. Applicants would be 

required to re-apply annually by 

completing this form and submitting to 

DEA. 

6. Obligation to Respond: Required to 

obtain or retain benefits. 

7. Total Estimated Number of 

Respondents: 9,000. 

8. Estimated Time per Respondent: 15 

minutes. 

9. Frequency: 1 per year. 

10. Total Estimated Annual Time 

Burden: 2,250 hours. 

11. Total Estimated Annual Other 

Costs Burden: $0. 

If additional information is required, 

contact: Darwin Arceo, Department 

Clearance Officer, Policy and Planning 

Staff, Justice Management Division, 

United States Department of Justice, 

Two Constitution Square, 145 N Street 

NE, 4W–218 Washington, DC 20530. 

Dated: November 25, 2024. 

Darwin Arceo, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2024–28045 Filed 11–27–24; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1125–0010] 

Agency Information Collection 

Activities; Proposed eCollection; 

eComments Requested; Extension of a 

Previously Approved Collection; 

Notice of Appeal to the Board of 

Immigration Appeals From a Decision 

of a DHS Officer (EOIR–29) 

AGENCY: Executive Office for 

Immigration Review, Department of 

Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Executive Office for 

Immigration Review (EOIR), Department 

of Justice (DOJ), will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 30 days until 

December 30, 2024. 

FOR FURTHER INFORMATION CONTACT: The 

proposed information collection was 

previously published in the Federal 

Register on September 13, 2024, 89 FR 

76510, allowing a 60 day-comment 

period. If you have additional comments 

especially on the estimated public 

burden or associated response time, 

suggestions, or need a copy of the 

proposed information collection 

instrument with instructions or 

additional information, please contact 

Zach Leciejewski, Attorney Advisor, 

Executive Office for Immigration 

Review, 5107 Leesburg Pike, Suite 2500, 

Falls Church, VA 22041, phone (703) 

305–0990 or email eoir.pra.comments@

usdoj.gov or Zach.Leciejewski@

usdoj.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Evaluate whether and if so how the 

quality, utility, and clarity of the 

information to be collected can be 

enhanced; and 


khammond on DSK9W7S144PROD with NOTICES